Literature DB >> 3135119

Distribution of subgroups of neuropeptide Y-immunoreactive and noradrenergic nerves in the female rat uterine cervix.

R E Papka1, H H Traurig.   

Abstract

Nerves in the uterine cervix of the rat were examined with regard to co-existence of markers for noradrenaline and neuropeptide Y, and differential tissue innervation by nerves containing different combinations of these markers. Immunohistochemical labeling of single and adjacent serial cryostat sections, and double labeling was employed. Some animals were treated with the noradrenergic neurotoxin, 6-hydroxydopamine. In control animals neuropeptide Y-immunoreactive fibers were numerous in the myometrium and around arteries; noradrenergic fibers were few in the myometrium and moderate in number around arteries. Myometrial neuropeptide Y-immunoreactive fibers were not decreased, but apparently increased, in 6-hydroxy-dopamine-treated rats; in contrast, perivascular neuropeptide Y-immunoreactive fibers were markedly reduced, but not totally absent. Noradrenergic fibers were absent in the myometrium and around arteries following 6-hydroxydopamine treatment. Labeling of adjacent sections and double labeling revealed coincident labeling of markers for neuropeptide Y and noradrenaline in perivascular, but not myometrial, nerves. We concluded that most myometrial neuropeptide Y-immunoreactive nerves did not contain noradrenaline since they were not sensitive to 6-hydroxydopamine and did not stain doubly; however, perivascular neuropeptide Y-immunoreactive fibers which degenerated after 6-hydroxydopamine treatment and did label doubly must co-store noradrenaline. Some neuropeptide Y-immunoreactive perivascular fibers may contain neuropeptide Y but not noradrenaline. Thus, it appears there is a differential innervation of tissues in the cervix by neuropeptide Y/noradrenergic nerves; this could reflect a differential regulation of tissues innervated by these nerves.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3135119     DOI: 10.1007/bf00216640

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  52 in total

1.  Neuropeptide Y-, substance P- and VIP-immunoreactive nerves in cat spleen in relation to autonomic vascular and volume control.

Authors:  J M Lundberg; A Anggård; J Pernow; T Hökfelt
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

2.  Effect of 6-hydroxydopamine on neuropeptides in the rat female genitourinary tract.

Authors:  J M Allen; J C Yeats; M A Blank; G P McGregor; J Gu; J M Polak; S R Bloom
Journal:  Peptides       Date:  1985 Nov-Dec       Impact factor: 3.750

3.  Distribution of galanin immunoreactivity in the genitourinary tract of man and rat.

Authors:  F E Bauer; N D Christofides; G W Hacker; M A Blank; J M Polak; S R Bloom
Journal:  Peptides       Date:  1986 Jan-Feb       Impact factor: 3.750

4.  Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function.

Authors:  J M Lundberg; L Terenius; T Hökfelt; C R Martling; K Tatemoto; V Mutt; J Polak; S Bloom; M Goldstein
Journal:  Acta Physiol Scand       Date:  1982-12

5.  Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides.

Authors:  C Wahlestedt; N Yanaihara; R Håkanson
Journal:  Regul Pept       Date:  1986-02

6.  Distribution, pathways and reactions to drug treatment of nerves with neuropeptide Y- and pancreatic polypeptide-like immunoreactivity in the guinea-pig digestive tract.

Authors:  J B Furness; M Costa; P C Emson; R Håkanson; E Moghimzadeh; F Sundler; I L Taylor; R E Chance
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

7.  Calcitonin gene-related peptide (CGRP) in the female rat urogenital tract.

Authors:  M A Ghatei; J Gu; P K Mulderry; M A Blank; J M Allen; J F Morrison; J M Polak; S R Bloom
Journal:  Peptides       Date:  1985 Sep-Oct       Impact factor: 3.750

8.  Neurotensin in the human fallopian tube: immunohistochemical localization and effects of synthetic neurotensin on motor activity in vitro.

Authors:  M Reinecke
Journal:  Neurosci Lett       Date:  1987-01-27       Impact factor: 3.046

9.  Origin and distribution of VIP (vasoactive intestinal polypeptide)-nerves in the genito-urinary tract.

Authors:  P Alm; J Alumets; R Håkanson; O Owman; N O Sjöberg; F Sundler; B Walles
Journal:  Cell Tissue Res       Date:  1980       Impact factor: 5.249

10.  Somatostatin is present in a subpopulation of noradrenergic nerve fibres supplying the intestine.

Authors:  M Costa; J B Furness
Journal:  Neuroscience       Date:  1984-11       Impact factor: 3.590

View more
  6 in total

1.  Distribution and origin of neuropeptide Y-immunoreactive fibers in the penis of the rat.

Authors:  Y Carrillo; E Fernandez; W G Dail; G Walton
Journal:  Cell Tissue Res       Date:  1991-04       Impact factor: 5.249

2.  Innervation of the anococcygeus muscle of the rat.

Authors:  W G Dail; Y Carrillo; G Walton
Journal:  Cell Tissue Res       Date:  1990-01       Impact factor: 5.249

3.  Studies on colocalization of neuropeptide Y, vasoactive intestinal polypeptide, catecholamine-synthesizing enzymes and acetylcholinesterase in the larynx of the rat.

Authors:  S Domeij; A Dahlqvist; S Forsgren
Journal:  Cell Tissue Res       Date:  1991-03       Impact factor: 5.249

4.  Galanin-immunoreactive nerves in the female rat paracervical ganglion and uterine cervix: distribution and reaction to capsaicin.

Authors:  R E Papka; H H Traurig
Journal:  Cell Tissue Res       Date:  1989-07       Impact factor: 5.249

5.  Calcitonin gene-related peptide (CGRP) in the nipple of the rat mammary gland.

Authors:  J Thulesen; T N Rasmussen; P Schmidt; J J Holst; S S Poulsen
Journal:  Histochemistry       Date:  1994-12

6.  Cervix remodeling and parturition in the rat: lack of a role for hypogastric innervation.

Authors:  Jonathan W Boyd; Thomas J Lechuga; Charlotte A Ebner; Michael A Kirby; Steven M Yellon
Journal:  Reproduction       Date:  2009-01-21       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.